EMvision Medical Devices Ltd Ordinary Shares EMV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$1.57
- Day Range
- A$1.54–1.58
- 52-Week Range
- A$1.47–1.96
- Bid/Ask
- A$1.57 / A$1.59
- Shares Outstanding
- 92.96M
- Market Cap
- A$145.94M
- Volume/Avg
- 23,683 / 32,456
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
EMvision Medical Devices Ltd is engaged in the research and development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The company's primary focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury. Both indications represent substantial societal and health economic burdens. It operates as a single segment in the research and development of medical device technology.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
- Website
- https://www.emvision.com.au
Valuation
|
Metric
|
EMV
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 9.26 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
EMV
|
|---|---|
Quick Ratio | 4.38 |
Current Ratio | 5.53 |
Interest Coverage | −42.14 |
Quick Ratio
EMV
Profitability
|
Metric
|
EMV
|
|---|---|
Return on Assets (Normalized) | −33.82% |
Return on Equity (Normalized) | −47.98% |
Return on Invested Capital (Normalized) | −40.02% |
Return on Assets
EMV
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|k%HxnNq | LOCK|mqjY> | $180B | |||
| Medtronic PLC
MDT
| LOCK|y>&P?t | LOCK|s&&Fq | $119B | |||
| Stryker Corp
SYK
| LOCK|?dSyzXB# | LOCK|m@f | $114B | |||
| Boston Scientific Corp
BSX
| LOCK|&^myf^ | LOCK|xX^B | $65B | |||
| Edwards Lifesciences Corp
EW
| LOCK|WftBWR$ | LOCK|LVlg | $50B | |||
| DexCom Inc
DXCM
| LOCK|?L%#B>P> | LOCK|P##m | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|lHsC<l | LOCK|>^ | $32B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|&y | LOCK|n^d | $25B | |||
| Steris PLC
STE
| LOCK|Xk$rk! | LOCK|TfTc | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|r#JW^&%% | LOCK|VtK | $18B |
United States